Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03537703 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current Stimulation and Effects on Early Auditory Processing in Schizophrenia
A NA study, sponsored by VA Greater Los Angeles Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT03537703 is a NA study that has completed, run by VA Greater Los Angeles Healthcare System. The registered enrollment target is 35 participants.
The verdict
NCT03537703, a NA study, has completed, sponsored by VA Greater Los Angeles Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
Individuals with schizophrenia have difficulties in functioning in the community. No one really knows what factors determine how well patients manage in the real world. The purpose of this pilot study is to try a new approach to improving a potential determinant of good community functioning, namely how we process sounds. Specifically, the investigators propose to examine the benefit of combining auditory training exercises with transcranial direct current stimulation (tDCS). tDCS is a new tool that is being developed as a safe and noninvasive neurostimulation method, for improving processing of sounds. Transcranial direct current stimulation involves placing a wet sponge electrode on the head and one on the arm. Electrical current from a device powered by a 9-volt battery will flow from one electrode to the other. A small portion of the current will pass through the skull and stimulate the brain. This procedure is non-invasive and painless and it results in increase or decrease of spontaneous neuronal firing in the brain. Neurons are brain cells that send electrochemical messages to each other. Its safety and beneficial effect on mental functions has been demonstrated in healthy individuals and several clinical populations. The purpose of this study is to determine if transcranial direct current stimulation added to auditory training exercises can improve how schizophrenia patients process sound.
Interventions
- COMBINATION_PRODUCT Active tDCS + Auditory Training
- COMBINATION_PRODUCT Active tDCS + Control Condition
- COMBINATION_PRODUCT Sham tDCS + Auditory Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2018-05-20 |
| Est. Completion | 2020-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03537703
The ClinicalTrials.gov registry entry for NCT03537703 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Greater Los Angeles Healthcare System, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Active tDCS + Auditory Training is the first listed.
NCT03537703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03537703 about?
NCT03537703 is a clinical study titled "Transcranial Direct Current Stimulation and Effects on Early Auditory Processing in Schizophrenia". Individuals with schizophrenia have difficulties in functioning in the community. No one really knows what factors determine how well patients manage in the real world. The purpose of this pilot study is to try a new approach to improving a potential determinant of good community functioning, namely...
What is the current status of trial NCT03537703?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2018-05-20. Estimated completion is 2020-05-01.
What interventions are being tested in trial NCT03537703?
The interventions under investigation include: Active tDCS + Auditory Training (COMBINATION_PRODUCT), Active tDCS + Control Condition (COMBINATION_PRODUCT), Sham tDCS + Auditory Training (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03537703?
This trial is sponsored by VA Greater Los Angeles Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.